Table 4.
PMA | Incidence of home oxygen (%)a | 24 0/7–25 6/7 wk (gestation at birth) | Incidence of home oxygen (%)a | 26 0/7–27 6/7 wk (gestation at birth) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
PPV (%) | Specificity (%) | Sensitivity (%) | NPV (%) | PPV (%) | Specificity (%) | Sensitivity (%) | NPV (%) | |||
30 wk | 61 | 39 | 48 | 90 | 85 | 54 | 54 | 78 | 76 | 91 |
31 wk | 70 | 70 | 74 | 67 | 71 | 69 | 69 | 89 | 72 | 90 |
32 wk | 86 | 86 | 91 | 57 | 70 | 79 | 79 | 95 | 60 | 88 |
33 wk | 90 | 90 | 96 | 43 | 65 | 92 | 92 | 99 | 48 | 88 |
34 wk | 100 | 100 | 100 | 33 | 63 | 100 | 100 | 100 | 40 | 83 |
Abbreviations: nCPAP, nasal continuous airway pressure; PMA, postmenstrual age; PPV, positive predictive value; NPV, negative predictive value.
Note: For definitions see ►Table 3.
Incidence of home oxygen therapy at discharge among infants who still need “mechanical ventilation or nCPAP” at a specific postmenstrual age (between 30 and 34 wk PMA).